Fig. 2: Schematic representation of NONO molecular mechanisms altered by NONO deregulation.
From: The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers
A Bladder cancer (BCa); B Epithelial ovarian cancer (EOC); PT-R and PT-S: resistant or sensitive to platinum, respectively; C Glioblastoma (GBM). TSS transcription start site. See the text for a detailed description of the panels.
